Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Cell Death & Disease
|
September 9, 2016
Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model
Qiang Liu, Longgui Chen, Jennifer M Atkinson, et al.
Breast Cancer Research : BCR
|
March 15, 2023
RET signaling in breast cancer therapeutic resistance and metastasis
Geoffrey Pecar, Simeng Liu, Jagmohan Hooda, et al.
Molecular Cancer Research : MCR
|
February 25, 2021
Exosomes in Breast Cancer - Mechanisms of Action and Clinical Potential
Tiantong Liu, Jagmohan Hooda, Jennifer M Atkinson, et al.
Developmental Biology
|
May 8, 2020
IGF1R constitutive activation expands luminal progenitors and influences lineage differentiation during breast tumorigenesis
Susan M Farabaugh, Beate C Litzenburger, Ashuvinee Elangovan, et al.
The New Bioethics : a Multidisciplinary Journal of Biotechnology and the Body
|
November 19, 2021
The Development and Implementation of an Autopsy/ Tissue Donation for Breast Cancer Research
Margaret Rosenzweig, Lori A Miller, Adrian V Lee, et al.
Plos Computational Biology
|
January 10, 2024
Systems approach for congruence and selection of cancer models towards precision medicine
Jian Zou, Osama Shah, Yu-Chiao Chiu, et al.
Plos One
|
April 28, 2015
Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3
Jennifer M Atkinson, Kenneth B Rank, Yi Zeng, et al.
Communications Biology
|
May 20, 2026
RET signaling as a mediator of estrogen receptor positive breast cancer brain metastasis
Simeng Liu, Geoffrey Pecar, Ye Cao, et al.
Biorxiv : the Preprint Server for Biology
|
October 4, 2023
<i>ESR1</i> fusion proteins invoke breast cancer subtype-dependent enrichment of ligand independent pro-oncogenic signatures and phenotypes
Megan E Yates, Zheqi Li, Yiting Li, et al.
Molecular Pharmaceutics
|
March 20, 2014
Tumor-targeted prodrug ICT2588 demonstrates therapeutic activity against solid tumors and reduced potential for cardiovascular toxicity
Jason H Gill, Paul M Loadman, Steven D Shnyder, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Cell Death & Disease
|
September 9, 2016
Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model
Qiang Liu, Longgui Chen, Jennifer M Atkinson, et al.
Breast Cancer Research : BCR
|
March 15, 2023
RET signaling in breast cancer therapeutic resistance and metastasis
Geoffrey Pecar, Simeng Liu, Jagmohan Hooda, et al.
Molecular Cancer Research : MCR
|
February 25, 2021
Exosomes in Breast Cancer - Mechanisms of Action and Clinical Potential
Tiantong Liu, Jagmohan Hooda, Jennifer M Atkinson, et al.
Developmental Biology
|
May 8, 2020
IGF1R constitutive activation expands luminal progenitors and influences lineage differentiation during breast tumorigenesis
Susan M Farabaugh, Beate C Litzenburger, Ashuvinee Elangovan, et al.
The New Bioethics : a Multidisciplinary Journal of Biotechnology and the Body
|
November 19, 2021
The Development and Implementation of an Autopsy/ Tissue Donation for Breast Cancer Research
Margaret Rosenzweig, Lori A Miller, Adrian V Lee, et al.
Plos Computational Biology
|
January 10, 2024
Systems approach for congruence and selection of cancer models towards precision medicine
Jian Zou, Osama Shah, Yu-Chiao Chiu, et al.
Plos One
|
April 28, 2015
Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3
Jennifer M Atkinson, Kenneth B Rank, Yi Zeng, et al.
Communications Biology
|
May 20, 2026
RET signaling as a mediator of estrogen receptor positive breast cancer brain metastasis
Simeng Liu, Geoffrey Pecar, Ye Cao, et al.
Biorxiv : the Preprint Server for Biology
|
October 4, 2023
<i>ESR1</i> fusion proteins invoke breast cancer subtype-dependent enrichment of ligand independent pro-oncogenic signatures and phenotypes
Megan E Yates, Zheqi Li, Yiting Li, et al.
Molecular Pharmaceutics
|
March 20, 2014
Tumor-targeted prodrug ICT2588 demonstrates therapeutic activity against solid tumors and reduced potential for cardiovascular toxicity
Jason H Gill, Paul M Loadman, Steven D Shnyder, et al.
Page
of 4